1. The desirability and feasibility of economic studies of drugs post-launch

   • Michael Drummond
   • Anne Mason
   • Adrian Towse

   Editorial Pages: 5 - 6

2. The relationship between health care expenditure and health outcomes

   • John Nixon
   • Philippe Ulmann

   Original Papers Pages: 7 - 18

3. Pharmacoeconomic modelling in schizophrenia

   • Karina Hansen
   • Christophe Lançon
   • Mondher Toumi

   Original Papers Pages: 19 - 29

   

4. Comparing costs and effectiveness of different starting points for highly active antiretroviral therapy in HIV-positive patients

   • Monica Merito
   • Patrizio Pezzotti
   • for the ICONA Study Group

   Original Papers Pages: 30 - 36

   

5. Fixed budgets as a cost containment measure for pharmaceuticals

   • David Granlund
   • Niklas Rudholm
   • Magnus Wikström

   Original Papers Pages: 37 - 45

   

6. The Danish effect on Swedish alcohol costs

   • Johan Jarl
   • Ulf-G. Gerdtham
   • Juan Merlo

   Original Papers Pages: 46 - 54

7. Prospective casemix-based funding, analysis and financial impact of cost outliers in all-patient refined diagnosis related groups in three Belgian general hospitals

   • Magali Pirson
   • Dimitri Martins
   • Pol Leclercq

   Original Papers Pages: 55 - 65

8. Case-control analysis of the financial cost of medication errors in hospitalized patients

   • Jaime Pinilla
   • Carles Murillo
   • Carlos Humet

   Original Papers Pages: 66 - 71

   

9. Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care

   • Steven J. Edwards
   • Helen E. Campbell
   • Jonathan M. Plumb

   Original Papers Pages: 72 - 78

   

10. Off-patent drugs in Italy

    • Livio Garattini
    • Simone Ghislandi

    Pricing and Reimbursement Systems in Europe Pages: 79 - 83

    

11. Thank you to the referees 2005

    Scentific information Pages: 84 - 84